Tremfya on Halftime Report

Halftime ReportJuly 29, 2026

Fed and Tech Earnings in Focus 7/29/26

1:06
mid-roll
Scott Wapner
CNBC
July 29, 2026
Announcer-readDirect responseBaked-in adHealthcare
0:00 / 1:06
@ 34:22 in ep

Transcript

For adults with Crohn's disease or ulcerative colitis symptoms, every choice matters. Tremphaya offers self-injection or intravenous infusion from the start. Tremphaya is administered as injections under the skin or infusions through a vein every four weeks, followed by injections under the skin every four or eight weeks. If your doctor decides that you can self-inject Tremphaya, proper training is required. Tremphaya is a prescription medicine used to treat adults with moderately to severely active Crohn's disease and adults with moderately to severely active ulcerative colitis. Serious allergic reactions, increased risk of infections or lower ability to fight them, and liver problems may occur. Before treatment, get checked for infections and tuberculosis. Tell your doctor if you have an infection, flu-like symptoms, or need a vaccine. Explore what's possible. Ask your doctor about Tremphaya today. Call 1-800-526-7736 to learn more or visit trimfireradio.com.

Auto-transcribed · verbatim audio matches · Report an error

Estimated ad cost

Unavailable

This show does not have a usable popularity input. AdReads leaves the estimate unavailable rather than manufacture a price.

Methodology and limitations →

Episode

Halftime Report
Fed and Tech Earnings in Focus 7/29/26
Host: Scott Wapner
Publisher: CNBC